ArticlePLoS computational biology2025
Graph-enhanced deep learning for diabetic retinopathy diagnosis: A quality-aware and uncertainty-driven approach.
Article in PLoS computational biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- A hybrid CNN-GNN and multitask learning pipeline for improving mild diabetic retinopathy sensitivity.MethodsX · 2026Article
- Reliability-aware fusion of ocular thermal imaging and radiometric features for proof-of-concept classification of diabetic retinopathy vs. healthy controls.Frontiers in medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Diabetic retinopathy (DR) is a leading cause of vision impairment, which significantly impacts working-class populations, necessitating accurate and early diagnosis for effective treatment. Traditional DR classification relies on Convolutional Neural Network (CNN)-based models and extensive preprocessing. In this work, we propose a novel approach leveraging pre-trained models for feature extraction, followed by Graph Convolutional Networks (GCNs) for refined embedding representation. The extracted feature vectors are structured as a graph, where GCN enhances embeddings before classification. The proposed model incorporates quality assessment by predicting a confidence score through a dedicated fully connected layer, trained to align with ground truth quality using binary cross-entropy loss. Uncertainty estimation is achieved by calculating the variance across multiple stochastic passes, providing a measure of the model's prediction reliability. We evaluate the proposed DR detection approach on APTOS2019, Messidor-2, and EyePACS datasets, achieving superior performance over state-of-the-art methods. Using MobileViT as the main feature extractor, we reached a remarkable 98.45% accuracy, 98.45% F1-Score, and 98.06% Kappa on the APTOS2019 dataset. The DenseNet-169 proved to be the best backbone of the pipeline for the Messidor-2 dataset, with an accuracy of 94.90%, F1-Score of 94.87%, and Kappa of 93.63%. Additionally, for external validation, the model demonstrated strong generalization capability on the EyePACS dataset, where DenseNet-169 achieved 97.38% accuracy, 97.37% F1-Score, and 96.72% Kappa, while MobileViT obtained 96.02% accuracy, 96.02% F1-Score, and 95.03% Kappa. Our innovative architecture incorporates uncertainty estimation and quality assessment techniques, enabling accurate confidence scores and enhancing the model's reliability in clinical environments. Furthermore, to strengthen interpretability and facilitate clinical validation, Grad-CAM heatmaps were employed to demonstrate the significance of different input regions on the model's predictions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.